What Will Be the Impact of the New IPT Consolidation Plan on P&MA in Spain?

Published on January 19, 2023

In December 2020, the Spanish MoH presented a plan to consolidate Therapeutic Positioning Reports (IPTs) with an aim to formally incorporate health-economic evaluations into these reports (e.g. cost-effectiveness). The key objectives of the plan are to:

  1. Consolidate IPTs as a reference tool in the positioning and cost-effectiveness evaluation of drugs within the healthcare system
  2. Improve the current Healthcare drug evaluation system through a governance process based on an expert evaluation network (REvalMED) and the use of tools that optimize the prioritization and tracking system for IPT development.

IPTs: a reference tool in the positioning and cost-effectiveness evaluation of drugs

Currently IPTs are an established resource leveraged by national and sub-national stakeholders and clinical experts to get informed about the clinical profile of a drug and its…

Continue reading on website
Other news

Commercial Creativity in Travel, Tourism, and Leisure: Beat the Fear of Failure

January 19, 2023
*//*-->*//*-->*//*-->*//*-->*//*-->*/Welcome to the faster future, where your monetization machine needs to run at a 100x higher speed. But are travel, tourism, and leisure companies bold enough to put their commercial creativity to the test? We caught up with Dimitris Hiotis, Alexander Frank, and Miguel Afán de Ribera to find out.Dimitris, your Travel Trends 2021 Study indicated considerable pent

The Pioneer’s Burden: Maximizing the Value Of Paradigm-Shifting Innovations

January 19, 2023
*//*-->*//*-->*//*-->*//*-->*//*-->*/Developers of disruptive medical technologies face a pioneer’s burden. They’re challenged with monetizing a unique product with no precedent to build upon. The medtech team of the market strategy consultancy Simon-Kucher & Partners shares its perspective on components of monetization strategies for companies offering paradigm-shifting products.In most industrie